Categories Earnings

Advance Auto Parts Q2 earnings to be boosted by recent initiatives

The aftermarket auto parts supplier Advance Auto Parts (AAP) is scheduled to report its second-quarter 2018 earnings on August 14 before the market opens. Analysts expect the company to report earnings of $1.86 a share and revenue of $2.26 billion.

In the first quarter, the company’s revenue failed to meet analysts’ expectations. Revenues came in at $2.87 billion, down 0.6% year over year. Earnings surged 31% to $2.10 per share, and surpassed analysts’ estimate.

When announcing the first quarter results, CEO Tom Greco stated that the company expects some improvement in Q2 sales, mainly due to rise in the customer demand in May.

With minor differences in business model, Advance Auto Parts’ competitor O’Reilly Auto Parts (ORLY) has been performing well. The Springfield, Missouri-based company reported an increase in sales and gross profit for its first quarter. AAP is making initiatives to get closer to O’Reilly.

RELATED: Advance Auto Parts shares fall after 1Q sales miss

In April, Advance Auto Parts entered into a partnership with Uber Technologies to become an exclusive after-market auto parts supplier for the Uber Visa Debit Card program for driver partners. AAP hopes that this new partnership will drive DIY traffic of its stores and websites. To cater to the evolving need of customers, the company is undertaking several initiatives to streamline its supply chain. The Roanoke, Virginia-based auto parts retailer has been working towards expanding its footprint by opening new stores and widening its online presence.

With a market cap of $10.84 billion, the company currently has a consensus rating of “Hold”. The stock has been trading between $78.81 and $148.70 in the past one year. Shares of AAP, which hit a new yearly high ($148.70) on August 9, were down about 1% towards the end of Monday’s trading session.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top